Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 4-((l-valyl)oxy)butanoic Acid
2. Xwl-008
3. Xw10172
4. 9b8nwp8k91
5. L-valine, 3-carboxypropyl Ester
6. Xw-10172
7. Refchem:1100924
8. Valiloxibic Acid
9. 238401-16-6
10. Valiloxybate [usan]
11. Valiloxybate (usan)
12. 4-[(2s)-2-amino-3-methylbutanoyl]oxybutanoic Acid
13. Starbld0003028
14. Valiloxybate [inn]
15. Unii-9b8nwp8k91
16. Orb1690933
17. Schembl3730354
18. Chembl5095201
19. Who 11367
20. Akos040757642
21. Da-58947
22. Ms-23099
23. Hy-137429
24. Cs-0138627
25. D12240
26. G18491
27. 4-{[(2s)-2-amino-3-methylbutanoyl]oxy}butanoic Acid
| Molecular Weight | 203.24 g/mol |
|---|---|
| Molecular Formula | C9H17NO4 |
| XLogP3 | -1.9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 7 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 89.6 |
| Heavy Atom Count | 14 |
| Formal Charge | 0 |
| Complexity | 203 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
85
PharmaCompass offers a list of Valiloxybate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Valiloxybate manufacturer or Valiloxybate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Valiloxybate manufacturer or Valiloxybate supplier.
A Valiloxybate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Valiloxybate, including repackagers and relabelers. The FDA regulates Valiloxybate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Valiloxybate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Valiloxybate supplier is an individual or a company that provides Valiloxybate active pharmaceutical ingredient (API) or Valiloxybate finished formulations upon request. The Valiloxybate suppliers may include Valiloxybate API manufacturers, exporters, distributors and traders.
Valiloxybate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Valiloxybate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Valiloxybate GMP manufacturer or Valiloxybate GMP API supplier for your needs.
A Valiloxybate CoA (Certificate of Analysis) is a formal document that attests to Valiloxybate's compliance with Valiloxybate specifications and serves as a tool for batch-level quality control.
Valiloxybate CoA mostly includes findings from lab analyses of a specific batch. For each Valiloxybate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Valiloxybate may be tested according to a variety of international standards, such as European Pharmacopoeia (Valiloxybate EP), Valiloxybate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Valiloxybate USP).
